Product Description
| Cat Number | T3550 |
|---|---|
| Category | Biochemical |
| Pack Size | 1EA |
| Description | X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion proteins, and ALK point mutation variants. Inhibition of ALK leads to the disruption of ALK-mediated signaling and eventually inhibits tumor cell growth in ALK-expressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development. |
| Molecular Weight | 547.41 |
| Purity | 0.9872 |
| Formula | C25H25Cl2FN6O3 |
| Smiles | C[C@@H](Oc1cc(nnc1N)C(=O)Nc1ccc(cc1)C(=O)N1CCN(C)CC1)c1c(Cl)ccc(F)c1Cl |
| Storage | -20 ℃ |
| View Document | |
| Note | This product is for Research Use Only |
Share Item: